{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:50:26Z","timestamp":1783479026900,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.prostaglandins.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T06:08:07Z","timestamp":1268633287000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase"],"prefix":"10.1016","volume":"92","author":[{"given":"Esther","family":"Titos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Horrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"L\u00f3pez-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Cl\u00e0ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/286264a0","article-title":"Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes","volume":"286","author":"Ford-Hutchinson","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi","volume":"288","author":"Dahlen","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1096\/fj.03-0053rev","article-title":"Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy","volume":"17","author":"Romano","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"Radmark","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.1840130316","article-title":"The sensitized liver represents a rich source of endogenous leukotrienes","volume":"13","author":"Hagmann","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/gast.2000.17831","article-title":"Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis","volume":"119","author":"Titos","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1189\/jlb.1204747","article-title":"Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells","volume":"78","author":"Titos","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1096\/fj.02-1157fje","article-title":"Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis","volume":"17","author":"Titos","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.107.128264","article-title":"Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor","volume":"323","author":"Horrillo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1665-2681(19)31810-1","article-title":"Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats","volume":"8","author":"El-Swefy","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib13","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1194\/jlr.M800101-JLR200","article-title":"Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice","volume":"49","author":"L\u00f3pez-Parra","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.ijo.0803147","article-title":"ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance","volume":"30","author":"Kaaman","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01966844","article-title":"Sex differences in the susceptibility of rats to carbon tetrachloride\u2013alcohol-induced liver injury","volume":"14","author":"Siegers","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib18","series-title":"Bioinformatics and computational biology solutions using R and bioconductor","first-page":"397","article-title":"Limma: linear models for microarray data","author":"Smyth","year":"2009"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1113\/jphysiol.2006.111484","article-title":"Functions of AMP-activated protein kinase in adipose tissue","volume":"574","author":"Daval","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib21","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1194\/jlr.R800052-JLR200","article-title":"Lipin proteins and metabolic homeostasis","volume":"50","author":"Reue","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.23463","article-title":"5-Lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice","volume":"51","author":"Mart\u00ednez-Clemente","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib23","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.0901355","article-title":"5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity","volume":"184","author":"Horrillo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpgasthep0084","article-title":"Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease","volume":"2","author":"Sanyal","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm","volume":"10","author":"Zhao","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000264498.60702.0d","article-title":"5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation","volume":"100","author":"Back","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.RES.0000028008.99774.7F","article-title":"Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice","volume":"91","author":"Mehrabian","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib29","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/ng1619","article-title":"Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits","volume":"37","author":"Mehrabian","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1098-8823(03)00039-X","article-title":"The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy","volume":"71","author":"Celotti","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2010.03.001_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bjp.0707645","article-title":"Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase","volume":"153","author":"Whittle","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:58:25Z","timestamp":1761098305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882310000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":31,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1098882310000225"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2010.03.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2010.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}